Fuad El-Hibri

Fuad Hibri (March 2, 1958 – April 23, 2022) was a German-American businessman and philanthropist, and founder of Emergent BioSolutions.[5]

Fuad Hibri
Fuad hibri.jpg
Official photo portrait of Fuad Hibri
Born(1958-03-02)March 2, 1958
DiedApril 23, 2022(2022-04-23) (aged 64)
NationalityLebanon, Germany
CitizenshipUnited States
Alma materStanford University; Yale University
Occupationchairman of the board of directors of Emergent BioSolutions[2]
Board member ofU.S. Chamber of Commerce; Yale Healthcare Conference; Hibri Charitable Foundation; International Biomedical Research Alliance; National Health Museum; Heifetz International Music Institute[3][4]
AwardsSee Awards and recognition

BiographyEdit

Early lifeEdit

Fuad El-Hibri was born in Hildesheim, Germany.[1] He spent his childhood equally in Europe and the Middle East before coming to the United States to get an economics degree from Stanford and an MBA from Yale.[6]

Early careerEdit

El-Hibri worked most of his career in the telecommunications industry. Between graduate school and working for BioPort and Emergent, he worked abroad, in countries including Indonesia, Saudi Arabia, Russia, Venezuela and El Salvador.[7]

El-Hibri served as president of Digicel from August 2000 to February 2005. He served as the president of East West Resources Corporation from September 1990 to January 2004.

He was a member of the senior management team of Speywood, LTD. in the United Kingdom and organized and directed the management buyout of Porton Products Ltd. El-Hibri reorganized Porton, and was advisor to the senior management team involved in the oversight of operations and served as a senior associate and resident project manager at Booz Allen Hamilton and as a manager of Citicorp in New York City (Mergers and Acquisitions), and in Jeddah, Saudi Arabia (Operations and Credit).

El-Hibri has been chairman of East West Resources Corporation, a venture capital and financial consulting firm, since June 1990. He served as the chairman of Digicel Holdings from August 2000 to October 2006. He serves as executive chairman of the board of Emergent BioDefense Operations Lansing Inc.

Emergent BioSolutions and BioPortEdit

El-Hibri has been the Emergent BioSolutions board of directors executive chairman since April 2012. He was both the board chairman and the CEO of the company from 2004 to 2012. He was the board chairman and CEO of BioPort Corporation from 1998 to 2004. Emergent acquired BioPort in 2004.[3]

His main role as the chairman of Emergent is to develop corporate strategy and mergers and acquisitions.[8]

After the 2001 anthrax attacks, some conspiracy theorists posted Internet websites that tried to imply that El-Hibri was connected to Osama Bin Laden and was connected to the anthrax attacks. USA Today interviewed El-Hibri in 2004 for an article about Muslim CEOs of companies helping to fight terrorism, and wrote, "El-Hibri calls the Web sites annoying and jokes that he's lucky to be in the vaccination business so that he can inoculate himself from the pain of accusers who can't be confronted."[1]

Charitable ActivityEdit

Fuad El-Hibri '82 Entrepreneurial AwardEdit

One of the Yale University School of Management donor-funded awards, the El-Hibri Award provides first year SOM students with internship program funding over the summer, seed capital for new businesses for second-year men and women and special funding for those going into early-stage start-up ventures. A group of 14 Yale alumni - entrepreneurs, innovators, and investors - choose the students who receive the awards, which total $100,000.[9]

Boards and leadership activitiesEdit

El-Hibri served on the boards of the U.S. Chamber of Commerce, International Biomedical Research Alliance, and National Health Museum. He also served on the advisory boards of the Heifetz International Music Institute and Yale Healthcare Conference.[10]

Personal lifeEdit

El-Hibri's mother is a German Catholic, and his father is a Lebanese businessman.[1] As a child, he lived in Germany and Lebanon.[7] He became a U.S. citizen in 1999.[1] He died on April 23, 2022 at Potomac, Maryland from pancreatic cancer.[5]

ReferencesEdit

  1. ^ a b c d e Beiser, H. Darr (May 18, 2004). "Muslim CEOs of U.S. firms fight terrorism, 'stop evil'". USA Today. Retrieved February 2, 2015.
  2. ^ Shay, Kevin James (March 30, 2012). "Emergent's Fuad El-Hibri, an entrepreneur at heart". Gazette.net. Archived from the original on August 1, 2013. Retrieved April 4, 2012.
  3. ^ a b "Fuad El-Hibri". Forbes. Archived from the original on October 11, 2012. Retrieved February 2, 2015.
  4. ^ "People: Fuad El-Hibri". Washington, D.C.: El-Hibri Foundation. Retrieved February 2, 2015.
  5. ^ a b Risen, Clay (April 30, 2022). "Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64". The New York Times.
  6. ^ Jones, Del (May 18, 2004). "Muslim CEOs of U.S. firms fight terrorism stop evil". USA Today. Retrieved May 3, 2010.
  7. ^ a b Censer, Marjorie (January 3, 2011). "CEO took roundabout path to Emergent". The Washington Post. Retrieved February 2, 2015.
  8. ^ Eckert, Barton (December 21, 2011). "Emergent BioSolutions Fuad El-Hibri to retire as CEO". Washington Business Journal. Washington, D.C.: American City Business Journals. Retrieved February 2, 2015.
  9. ^ Guzman, Karen. "Fifteen Student Startups Win 2019 Entrepreneurial Awards". Yale School of Management. New Haven CT: Yale University. Retrieved August 31, 2020.
  10. ^ "Fuad El-Hibri – East West Protection, LLC". Retrieved April 7, 2015.

External linksEdit